A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin.
Alexander
Duane
D
National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-2425, USA. da43w@nih.gov
D001663:Bilirubin / Q000096:biosynthesis*; D017277:Drug Approval; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006419:Heme Oxygenase (Decyclizing) / Q000037:antagonists & inhibitors*; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000188:drug therapy*; D008665:Metalloporphyrins / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D004791:Enzyme Inhibitors; D008665:Metalloporphyrins; C055421:tin mesoporphyrin; D006419:Heme Oxygenase (Decyclizing); D001663:Bilirubin